PMON135
Ongoing Remote CDCES Support Improves Glycemic Control and Time in Range for CGM Naïve Individuals with Type 2 Diabetes Arnold Saperstein, MD, FACP; Teresa McArthur, MS, RD, CDCES • Cecelia Health Background � The combination of limited access to Diabetes Self-Management & Education Services (DSMES) and hesitancy of primary care providers to prescribe continuous glucose monitors (CGM) has led to limited adoption of Time in Range (TIR) as a metric of evaluation of glucose control for individuals with Type 2 Diabetes. � Research suggests that TIR is a better metric to evaluate glucose control and overall diabetes management than HbA1c.
ceceliahealth.com
Conclusion
There are significant benefits of a virtual diabetes care model on improving TIR and promoting successful device adoption
This case demonstrates the significant benefits of a virtual diabetes care and support model at: � Promoting successful device adoption � Improving Time in Range � Supporting expanded prescription of CGMs paired with adequate clinical support This model can be applied more broadly to solve for patient access to specialty care services and reduce the burden to primary care providers.
Clinical Case Patient: 64-year-old male Diagnosis: Type 2 Diabetes (at age 47) Patient was referred to Cecelia Health’s virtual clinic in a clinical study setting. The goal of the study was to evaluate a fully virtual remote diabetes care model paired with behavioral health interventions. As indicated by clinical intake assessments, the patient: � Displayed a significant fear of hypoglycemia, contributing to behavior that led to a high blood glucose and low TIR � Expressed frustration with the burden of managing diabetes while living alone � Had no previous experience utilizing CGM
Our approach The endocrine team prescribed a leading CGM device and referred the patient to a six-month remote clinical support program. The CDCES-led, personalized sessions focused on insulin education, CGM support, behavioral support to address fears, and data analysis designed to raise overall disease state literacy level. TIR improvement After 6 months, patient readings meet TIR targets
25%
83%